Hoth Therapeutics Standard Deviation
| HOTH Stock | | | USD 0.67 -0.02 -2.90% |
The Standard Deviation is a measure of how spread out the prices or returns of an asset are on average. It is the most widely used risk indicator in the field of investing and finance. Standard Deviation is commonly used to measure confidence in statistical conclusions regarding certain equity instruments or portfolios of equities. Below is Hoth Therapeutics's current Standard Deviation with peer comparisons and related risk metrics.
Current Standard Deviation Value
The Standard Deviation of 7.04 for Hoth Therapeutics indicates elevated price variability. This places Hoth Therapeutics toward the higher end of the volatility range for Pharmaceuticals.
Standard Deviation | = | SQRT(V) |
| = | 7.04 | |
Standard Deviation Peers Comparison
The peer group averages 7.77 for Standard Deviation, with Hoth Therapeutics at 7.04 falling below that level. Readings span 3.94 (Briacell Therapeutics Corp) to 13.65 (Aspire BioPharma). Hoth Therapeutics has exhibited less price dispersion than the peer average over the measured period.
Standard Deviation Relative To Other Indicators
The chart below plots Standard Deviation against Maximum Drawdown for Hoth Therapeutics and its peers. Each point represents one equity — position along the horizontal axis shows Standard Deviation while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
At
7.04 for Standard Deviation and
48.52 for Maximum Drawdown, Hoth Therapeutics's cross-indicator ratio sits almost
6.90 . This indicates Maximum Drawdown substantially exceeds Standard Deviation for Hoth Therapeutics.
Compare Hoth Therapeutics to PeersMethodology, Assumptions & Data Sources
Hoth Therapeutics' Standard Deviation currently stands at 7.04. The Standard Deviation for Hoth Therapeutics is produced by transforming raw price history into a standardized measure according to the indicator's defined methodology. Price data is sourced from standardized end-of-day feeds across supported exchanges, normalized for corporate actions. Hoth Therapeutics operates in the health care sector, which may exhibit distinct volatility and momentum characteristics relative to the broader market. The calculation assumes continuous price data across the selected period. All readings are presented as reference data.
Other Technical Indicators